Back to Journals » Drug Design, Development and Therapy » Volume 12

Update on new biologics for intractable eosinophilic asthma: impact of reslizumab

Total article views   HTML views PDF downloads Totals
23,076 Dovepress* 19,529+ 1,183 20,712
PubMed Central* 3,547 534 4,081
Totals 23,076 1,717 24,793
*Since 8 May 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar